Survival in CRCa patients in this study as related to tumor stage and recurrence
Patients in this study that died of CRC survived 22 ± 17 months whereas those that survived >5 years were followed or lived 147 ± 45 months. All of the deaths in patients living ≤ 5 years were cancer-related (i.e., local recurrences, growth of primary tumor, resistance to therapy, metastases, or new primary cancers). Clinical follow-up information was available for 30 of 33 total cancer cases evaluated in this study. These 30 cases are represented in this table. See “Materials and Methods” for pathological staging.
Survival | Stage 0 (n) (%) | Stage I (n) (%) | Stage II (n) (%) | Stage III (n) (%) | Stage IV (n) (%) |
---|---|---|---|---|---|
Living > 5 years | 3/3 (100%) | 5/5 (100%) | 7/8 (87.5%) | 3/10 (30%) | |
Living ≤ 5 years | 1/8 (12.5%) | 7/10 (70%) | 4/4 (100%) |
a CRC, colorectal cancer.